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1 Datasets
We used 16 biomedical corpora representing 15 NER corpora and one part-of-speech (POS)
corpus. Details of their creation, prior use, and conversion into the CoNLL format used to train,
develop and test our methods are presented in the following.
1.1 AnatEM corpus
The extended Anatomical Entity Mention corpus (Pyysalo and Ananiadou, 2013) is the result
of combining and extending the Anatomical Entity Mention (AnEM) corpus (Ohta et al., 2012)
and the Multi-level Event Extraction corpus (MLEE) (Pyysalo et al., 2012a). AnEM consists of
500 randomly selected PubMed abstracts and full-text extracts annotated for anatomical entity
mentions. MLEE consists of 262 PubMed abstracts on the molecular mechanisms of cancer,
specifically relating to angiogenesis. MLEE is also annotated for anatomical entities specified in
AnEM.
AnatEM was created by combining the anatomical entity annotations of the AnEM and
MLEE corpora, then manual annotation was done on an additional 100 documents following
the selection criteria of AnEM and 350 documents following those of MLEE, for a selection of
topics related to cancer. The resulting corpus thus consists of 1212 documents, 600 of which
are drawn randomly from abstracts and full texts as in AnEM, and the remaining 612 are a
targeted selection of PubMed abstracts relating to the molecular mechanisms of cancer.
Conversion The AnatEM corpus data is available from http://nactem.ac.uk/
anatomytagger/ in multiple formats, including CoNLL-style IOB, and is provided with
a pre-defined split into train, development and test subsets. We use this data in a single-class
NER setting, mapping all NE labels to Anatomy, but otherwise without modification; the
number of annotations and their spans are thus identical to the source data.
1.2 BC2GM corpus
The BioCreative II Gene Mention (BC2GM) task corpus consists of 20,000 sentences from
biomedical publication abstracts and is annotated for mentions of the names of genes, pro-
teins and related entities using the single NE class Gene (Smith et al., 2008). It has become the
major NER benchmark for gene/proteins names and has been used to train and evaluate many
available NER systems such as BANNER (Leaman and Gonzalez, 2008) and Gimli (Campos et
al., 2013).
Conversion The BC2GM corpus is available from http://www.biocreative.org/ in a cus-
tom standoff format and a standard train/test split. We created a development set by splitting
off 2,500 sentences from the training data and converted the corpus into CoNLL format using
tools available from https://github.com/spyysalo/bc2gm-corpus.
The BC2GM corpus has the unique feature of defining alternative boundaries for some of the
annotated names. For the conversion, we only used the primary annotations (GENE.eval files),
which could be represented highly accurately in the CoNLL format: the converted data contained
99.95% of the number of annotations in the original. No differences from token boundaries were
introduced: all names in the converted data matched names in the source data.
1.3 BC4CHEMD corpus
The BioCreative IV Chemical and Drug (BC4CHEMD) named entity recognition task corpus
consists of 10,000 abstracts annotated for mentions of chemical and drug names using a single
class, Chemical (Krallinger et al., 2015).
Conversion The BC4CHEMD corpus data is available from http://www.biocreative.org/
in a TAB-separated standoff format and defines standard training, development and test sub-
sets. We converted the data into CoNLL format using custom tools available from https:
//github.com/spyysalo/chemdner-corpora, mapping non-ASCII characters to ASCII. The
basic conversion is highly accurate; the number of annotations in the converted data is 99.95%
of that in the source. Non-ASCII characters in the source and tokenization differences lowered
the number of matching strings somewhat, to 97.16%.
1.4 BC5CDR corpus
The BioCreative V Chemical Disease Relation (CDR) corpus was created for the BioCreative
V Chemical Disease Relation (CDR) Task (Wei et al., 2015) and consists of human annotations
of all chemicals, diseases and their interactions in 1,500 PubMed articles. 1,400 of these articles
were selected from an existing 150,000 chemical-disease interactions which were annotated by
CTD-Pfizer. The CTD biocurators followed CTDs rigorous curation process and curated in-
teractions from mostly just the abstract, but referenced the full text when it was necessary to
resolve relevant issues mentioned in the abstract. The remaining 100 articles were completely
new.
Conversion The BC5CDR corpus is available in BioC (Comeau et al., 2013) and PubTator
(Wei et al., 2013) formats from http://www.biocreative.org/ with pre-defined training, devel-
opment and test subsets. We converted the chemical and disease annotations of the corpus from
the PubTator format using tools available from https://github.com/spyysalo/pubtator. The
conversion introduced only minimal divergence, increasing the annotation number by two to
100.01% of the original due to sentence splitting errors inside annotation spans. 99.94% of the
annotated strings in the source match those in the converted data, reflecting rare instances
where annotation boundaries occurred inside alphanumeric tokens.
1.5 BioNLP09 corpus
The BioNLP’09 shared task on event extraction (Kim et al., 2009) targeted semantically rich
event extraction, involving the extraction of several different classes of information. To focus
on these novel aspects of the event extraction task, it was assumed that NER has already been
performed and the task began with a given set of gold protein annotations. The named entities
in the BioNLP task data were prepared based on the GENIA event corpus. Part of the data
were derived from the publicly available event corpus (Kim et al., 2008), and the remainder from
an unpublished portion of the corpus.
Conversion The BioNLP’09 shared task data is available from www.nactem.ac.uk/tsujii/
GENIA/SharedTask/ in the .ann standoff format first introduced for the task. We use the
Protein annotations of the corpus (the only physical entity annotations released also for its
test data) and the training, development and test split of the original dataset. The data was
converted from standoff to the CoNLL format using the standoff2conll tool available from
https://github.com/spyysalo/standoff2conll.
After conversion, the number of annotations was 99.96% of the number in the source, and
99.69% of names in the original data matched names in the converted data (ignoring whitespace),
indicating that almost all of the original annotations could be exactly represented in the CoNLL
format with the applied tokenization.
1.6 BioNLP11 corpora
Similar to the BioNLP’09 task, the BioNLP Shared Task 2011 (Kim et al., 2011; Pyysalo et al.,
2012b) was focused on semantically rich tasks such as Infectious Diseases (ID) and Epigenetics
and Post-translational Modifications (EPI). The ID task was concerned with the molecular
mechanisms of infection, virulence and resistance while the EPI task focused on the extraction
of statements regarding chemical modifications of DNA and proteins. Both tasks used manual
annotations created specifically for the shared task, with automatic support for the initial tagging
of named entities.
The texts for the EPI task corpus were drawn from PubMed abstracts annotated with the
MeSH term corresponding to the target event (e.g. Acetylation). Protein/Gene entity mentions
in the selected abstracts were automatically tagged using the BANNER (Leaman and Gonzalez,
2008) named entity tagger trained on the GENETAG (Tanabe et al., 2005) corpus. Abstracts
where fewer than five entities are found were removed and documents not relevant to the targeted
topic were also manually removed.
The data for the ID corpus were drawn from the primary text content of full-text PMC open
access documents deemed by infectious diseases domain experts to be representative publications
on two-component regulatory systems. The annotation of the Protein entities was performed
automatically using NeMine (Sasaki et al., 2008) trained on the JNLPBA data (Kim et al.,
2004) with threshold 0.05, filtered to only GENE and Protein types.
Conversion The BioNLP’11 corpora are available from http://2011.bionlp-st.org/ in the
standoff format used for the BioNLP’09 data (Section 1.5). We use the standard training, de-
velopment and test sets of each of the BioNLP’11 corpora and all physical entity annotations
released for all subsets of the two corpora. Conversion was performed with the standoff2conll
tool. As the BioNLP’11 ID task data contained a large number of annotations where more than
one name occurred inside the span of another annotation (e.g. Regulon-operon or Two-
component-system), we resolved overlaps in favor of keeping the shorter of any pair of over-
lapping annotations,1 thus maximizing the number of annotations carried over from the source.
Notably, this overlap pattern occurred for all 492 Two-component-system annotations in the
corpus (3.8% of all annotations), leading to the elimination of this annotation type from the
converted data.
The converted EPI data contains 99.87% of the number of annotations in the source, but just
94.86% of originals matched converted in text, reflecting a comparatively high number of cases
where an annotation boundary occurred within an alphanumeric token. For ID, the number of
annotations fell to 86.99% in conversion, reflecting the frequent pattern of annotation overlap.
The fraction of matching names was 85.53%, indicating that annotation boundaries rarely differ
from token boundaries.
1.7 BioNLP13 corpora
The BioNLP 2013 Shared Task focused on knowledge-based construction. There were six tasks
in this Shared Task, of which three datasets were used for our work: GENIA Event Extraction
(GE), Cancer Genetics (CG) and Pathway Curation (PC).
The GE corpus consists of 20 full paper articles sourced from PubMed Central Open Access
subset (PMCOA) with 7721 spans manually annotated as protein names (Kim et al., 2013).
The CG task corpus consists of 600 PubMed abstracts annotated for over 17,000 events and
was prepared as an extension of the MLEE (Pyysalo et al., 2012a) corpus of 250 abstracts (c.f.
1Option -o keep-shorter for standoff2conll
Section 1.1). The PC task corpus consists of 525 PubMed abstracts, chosen for the relevance to
specific pathway reactions selected from SBML models registered in BioModels and PANTHER
DB repositories (Mi and Thomas, 2009). The corpus was manually annotated for over 12,000
events on top of close to 16,000 entities.
Conversion The BioNLP’13 corpora are available from http://2013.bionlp-st.org/ in the
same standoff format as the ’09 and ’11 corpora (Sections 1.5 and 1.6). As for these resources,
we use the standard training, development and test set splits of each corpus and all of the
physical entity annotations available for each dataset, and perform the conversion using the
standoff2conll tool. Of the BioNLP’13 corpora only the CG task involved overlap between
annotations in the source data; these were resolved in favor of keeping the shorter annotations,
as for BioNLP’11 ID processing.
The conversion was highly accurate for all three of the BioNLP’13 corpora: the numbers of
annotations in the converted data were 99.07%, 99.91%, and 99.95% of the numbers of anno-
tations in the source for CG, GE, and PC respectively. Similarly, the fractions of annotated
strings matching after conversion were 98.67%, 98.79%, and 99.80% (resp.).
1.8 Colorado Richly Annotated Full Text (CRAFT) corpus
The CRAFT corpus (Bada et al., 2012; Verspoor et al., 2012) consists of 67 full-text articles,
over 790,000 Tokens, over 21,000 Sentences and approximately 140,000 concept annotations. It
manually annotates all mentions of nearly all concepts from nine prominent biomedical ontologies
and terminologies: Cell Type Ontology, Chemical Entities of Biological Interest ontology, NCBI
Taxonomy, Protein Ontology, Sequence Ontology, Entrez Gene database entries, and the three
sub-ontologies of the Gene Ontology. There was emphasis on journal articles that comprise the
corpus being drawn from diverse biomedical disciplines and on them being completely annotated.
We use the annotated physical entities from this corpus.
1.8.1 Conversion
The 67 publicly released articles of the CRAFT corpus are available in multiple formats from
http://bionlp-corpora.sourceforge.net/CRAFT/. We split the data into 34 training, 11 de-
velopment and 22 test documents and created a custom conversion for the corpus from the Know-
tator format (Ogren, 2006). Of the resources considered in this study, the CRAFT term annota-
tions represented the most challenges for use in sequence labeling: these are frequently overlap-
ping, occasionally discontinuous, and associated with ontology identifiers (e.g. PR:000009758)
rather than simple labels such as Protein. To convert the corpus, we first excluded annotations
not associated with physical entity types (biological process/molecular function, coreference, sec-
tions and typography). We then merged annotations associated with gene (EntrezGene) and
protein (PR) identifiers, which frequently mark identical spans in the source data, into a sin-
gle gene/gene-product type. We likewise merged those referencing organism and taxonomic
rank vocabularies. We finally deduplicated the resulting annotations and resolved remaining
overlapping and discontinuous entities with corpus-specific heuristics implemented in a custom
tool available from https://github.com/spyysalo/knowtator2standoff/.
The resulting dataset contains 72.05% of the number of annotations in the physical entity-
associated subsets of CRAFT (chebi, cl, entrezgene, go-cc, ncbitaxon, pr, and so), with
69.76% of the annotated names in the source matching ones in the converted data. These
numbers are by far the lowest among the corpora considered here. While most of the difference
reflects fundamental limitations of the BIO representation, many decisions in the conversion
could reasonably be made in another way and our results on CRAFT should thus not be directly
compared to others where a different conversion of the data has been used.
1.9 Ex-PTM corpus
The Exhaustive Post-Translational Modifications corpus (Pyysalo et al., 2011) was part of the
BioNLP Shared Task 2011 and employed a similar creation methodology to that of the BioNLP11
EPI task corpus (c.f. Subsection 1.6). It annotated 360 PubMed abstracts containing 76,806
words of which 4,698 were annotated as proteins. Though the more semantically complex PTM
identification task used manual annotations, the Protein/Gene entity mentions were automati-
cally tagged using the BANNER (Leaman and Gonzalez, 2008) named entity tagger trained on
the GENETAG (Tanabe et al., 2005) corpus. Abstracts containing fewer than five entities were
removed and a randomly chosen subset of the remaining documents were annotated.
Conversion The Exhaustive PTM corpus is available from http://www.geniaproject.org/
in the standoff format used by the BioNLP corpora (Section 1.5). Unlike the shared task
resources, the Ex-PTM corpus does not come with a pre-defined development set, but only
a split between training and test data; we thus split off 49 of the 196 test documents as a
development set. Conversion of the single physical entity annotation type, Protein, was again
performed with standoff2conll. As the source data contained a small number of non-ASCII
characters, the conversion tool was run with the -a option to map these to ASCII.
The conversion exactly preserves the number of annotations in the source data. However, as
for the BioNLP’11 EPI corpus (Section 1.6) with which the Ex-PTM corpus shares a domain
and some development history, the fraction of original names matching the text of converted
names is notably lower at 95.72%, reflecting comparatively frequent entity mention boundaries
inside alphanumeric tokens.
1.10 JNLPBA corpus
The Joint workshop on NLP in Biomedicine and its Applications corpus consists of 2,404 pub-
lication abstracts (approx. 22,400 sentences) and is annotated for mentions of five entity types:
cell line, cell type, DNA, RNA, and protein (Kim et al., 2004). The corpus was derived
from GENIA corpus entity annotations. It is now a standard point of reference for evaluat-
ing multi-class biomedical entity taggers and has served as training material for tools such as
ABNER (Settles, 2005) and the GENIA Tagger.
Conversion The JNLPBA corpus is available from http://www.geniaproject.org/ and dis-
tributed in the CoNLL IOB format with a split into train and test subsets. To create the
development set, we separated 200 of the 2000 documents from the training data. As format
conversion was not required, the annotations match the original data exactly.
1.11 LINNAEUS corpus
The LINNAEUS corpus (Gerner et al., 2010) consists of 100 full-text documents from the PM-
COA document set which were randomly selected. All mentions of species terms were manually
annotated and normalized to the NCBI taxonomy IDs of the intended species.
Conversion The LINNAEUS corpus is available from http://linnaeus.sourceforge.net/
in a TAB-separated standoff format. The resource does not define training, development or test
subsets. We converted the corpus into BioNLP shared task standoff format using a custom script
available from https://github.com/spyysalo/linnaeus-corpus, split it into 50-, 17-, and 33-
document training, development and test sets, and then converted these into the CoNLL format
using standoff2conll. As a full-text corpus, LINNAEUS contains comparatively frequent
non-ASCII characters, which were mapped to ASCII using the standoff2conll -a option.
The conversion was highly accurate, but due to sentence-splitting errors within entity men-
tions, the number of annotations in the converted data was larger by four (100.09%) than that
in the source data. 99.77% of names in the original annotation matched names in the converted
data.
1.12 NCBI Disease corpus
The NCBI Disease corpus (Dog˘an et al., 2014) consists of 793 PubMed abstracts fully annotated
at the mention and concept level for disease mentions. The public release of the NCBI disease
corpus contains 6,892 disease mentions, which are mapped to 790 unique disease concepts. Of
these, 88% link to a MeSH identifier, while the rest contain an OMIM identifier. 91% of the
mentions were linked to a single disease concept, while the rest are described as a combination
of concepts.
Conversion The NCBI Disease corpus is available in a TAB-separated standoff format with
a standard split into training, development and test subsets from http://www.ncbi.nlm.nih.
gov/CBBresearch/Dogan/DISEASE/. We converted the corpus annotations to CoNLL format
using tools available from https://github.com/spyysalo/ncbi-disease. The converted num-
ber of annotations was 99.84% of the original number, with 99.81% of strings in the original
annotations matching with converted data. The differences were mostly due to a duplicated
document in the source data.
1.13 GENIA POS
The GENIA corpus is one of the most widely used resources for biomedical NLP and has a
rich set of annotations including parts of speech, phrase structure syntax, entity mentions, and
events (Ohta et al., 2002). For this work we use the GENIA POS annotations, which cover 2000
PubMed abstracts (approx. 20,000 sentences).
Conversion We use the GENIA corpus v3.02 POS annotations that were used to train
the GENIA tagger (Tsuruoka et al., 2005), available from https://github.com/spyysalo/
genia-pos.2 We split off 210 of the 1790 training set documents into a development test. The
data is distributed in a tagged-token format that could be straightforwardly recast into the
CoNLL format, preserving both the tokenization and the annotations of the original exactly.
2 Full Effects Results
To determine the exact effect that each NER dataset had on every other one, the multi-task
model described in the paper was used to train each NER dataset with every other one. That
is, a Multi-output multi-task model was trained for each ordered combination of the datasets to
give 15 x 14 models. The best results for each dataset was included in the paper, but the full
set of all results could not be included for space considerations. They are added in Table 1.
Table 1: Full Effects Results. (*: best score)
Dataset Scores
AnatEM BC2GM: 80.63, BC4CHEMD: 77.72, BC5CDR: 80.85, BioNLP09: 80.99,
BioNLP11EPI: 80.81, BioNLP11ID: 81.22, BioNLP13CG: 81.14,
BioNLP13GE: 81.48, BioNLP13PC: 81.03, CRAFT: 80.03, Ex-PTM: 81.57,
JNLPBA: 78.20, Linnaeus: 80.94, NCBI-Disease: 81.68*
BC2GM AnatEM: 72.07, BC4CHEMD: 68.32, BC5CDR: 71.80, BioNLP09: 71.43,
BioNLP11EPI: 71.95, BioNLP11ID: 71.56, BioNLP13CG: 71.68,
BioNLP13GE: 72.17, BioNLP13PC: 72.04, CRAFT: 70.20, Ex-PTM: 72.21*,
JNLPBA: 69.35, Linnaeus: 71.64, NCBI-Disease: 71.84
BC4CHEMD AnatEM: 79.58, BC2GM: 78.84, BC5CDR: 79.43, BioNLP09: 79.34
BioNLP11EPI: 79.91, BioNLP11ID: 79.35, BioNLP13CG: 78.98,
BioNLP13GE: 80.31*, BioNLP13PC: 79.54, CRAFT: 78.19, Ex-PTM: 80.29,
JNLPBA: 77.37, Linnaeus: 79.39, NCBI-Disease: 79.57
BC5CDR AnatEM: 83.21, BC2GM: 82.54, BC4CHEMD: 81.45, BioNLP09: 83.18,
BioNLP11EPI: 83.77*, BioNLP11ID: 83.38, BioNLP13CG: 83.66,
BioNLP13GE: 83.54, BioNLP13PC: 83.58, CRAFT: 81.95, Ex-PTM: 83.03,
2We are grateful to Yoshimasa Tsuruoka for providing this version of the corpus, which differs from that
available from http://www.geniaproject.org/ most importantly in providing a train/test split.
Table 1: Full Effects Results. (*: best score)
Dataset Scores
JNLPBA: 81.10, Linnaeus: 83.28, NCBI-Disease: 83.72
BioNLP09 AnatEM: 83.24, BC2GM: 83.56, BC4CHEMD: 81.89, BC5CDR: 83.35,
BioNLP11EPI: 84.14, BioNLP11ID: 83.50, BioNLP13CG: 83.68,
BioNLP13GE: 84.16*, BioNLP13PC: 83.53, CRAFT: 82.97, Ex-PTM: 83.86,
JNLPBA: 82.29, Linnaeus: 82.78, NCBI-Disease: 83.55
BioNLP11EPI AnatEM: 76.62, BC2GM: 76.60, BC4CHEMD: 74.48, BC5CDR: 76.67,
BioNLP09: 78.10*, BioNLP11ID: 76.86, BioNLP13CG: 76.97,
BioNLP13GE: 77.49, BioNLP13PC: 77.14, CRAFT: 75.80, Ex-PTM: 77.99,
JNLPBA: 74.87, Linnaeus: 76.62, NCBI-Disease: 76.51
BioNLP11ID AnatEM: 81.43, BC2GM: 81.35, BC4CHEMD: 77.16, BC5CDR: 81.43,
BioNLP09: 81.87, BioNLP11EPI: 81.76, BioNLP13CG: 81.90,
BioNLP13GE: 82.26*, BioNLP13PC: 81.66, CRAFT: 80.36, Ex-PTM: 81.73,
JNLPBA: 78.80, Linnaeus: 81.62, NCBI-Disease: 81.78
BioNLP13CG AnatEM: 75.85, BC2GM: 73.94, BC4CHEMD: 68.73, BC5CDR: 76.05,
BioNLP09: 75.41, BioNLP11EPI: 75.78, BioNLP11ID: 76.58,
BioNLP13GE: 76.26, BioNLP13PC: 77.33*, CRAFT: 74.08, Ex-PTM: 77.16,
JNLPBA: 70.46, Linnaeus: 75.09, NCBI-Disease: 75.72
BioNLP13GE AnatEM: 74.05, BC2GM: 74.08, BC4CHEMD: 73.19, BC5CDR: 73.48,
BioNLP09: 75.99, BioNLP11EPI: 76.09*, BioNLP11ID: 73.66,
BioNLP13CG: 75.35, BioNLP13PC: 73.99, CRAFT: 75.46, Ex-PTM: 73.78,
JNLPBA: 74.15, Linnaeus: 74.16, NCBI-Disease: 74.05
BioNLP13PC AnatEM: 79.61, BC2GM: 77.78, BC4CHEMD: 75.72, BC5CDR: 79.79,
BioNLP09: 79.08, BioNLP11EPI: 79.31, BioNLP11ID: 80.67,
BioNLP13CG: 80.36, BioNLP13GE: 80.76, CRAFT: 77.66, Ex-PTM: 80.94*,
JNLPBA: 78.73, Linnaeus: 78.60, NCBI-Disease: 79.55
CRAFT AnatEM: 77.08, BC2GM: 76.97, BC4CHEMD: 73.61, BC5CDR: 77.97,
BioNLP09: 77.70, BioNLP11EPI: 77.61, BioNLP11ID: 78.10,
BioNLP13CG: 77.30, BioNLP13GE: 78.48*, BioNLP13PC: 77.93, Ex-PTM: 78.36,
JNLPBA: 74.86, Linnaeus: 77.38, NCBI-Disease: 77.43
Ex-PTM AnatEM: 68.45, BC2GM: 68.35, BC4CHEMD: 60.33, BC5CDR: 69.46,
BioNLP09: 72.00, BioNLP11EPI: 73.58*, BioNLP11ID: 69.58,
BioNLP13CG: 68.82, BioNLP13GE: 70.07, BioNLP13PC: 70.36, CRAFT: 67.25,
JNLPBA: 62.60, Linnaeus: 69.20, NCBI-Disease: 68.49
JNLPBA AnatEM: 68.19, BC2GM: 68.20, BC4CHEMD: 66.49, BC5CDR: 68.77,
BioNLP09: 68.11, BioNLP11EPI: 68.33, BioNLP11ID: 68.19,
BioNLP13CG: 68.54, BioNLP13GE: 68.92*, BioNLP13PC: 68.84, CRAFT: 67.97,
Ex-PTM: 68.84, Linnaeus: 68.18, NCBI-Disease: 68.51
Linnaeus AnatEM: 83.23, BC2GM: 81.71, BC4CHEMD: 79.24, BC5CDR: 82.83,
BioNLP09: 83.12, BioNLP11EPI: 82.20, BioNLP11ID: 81.77,
BioNLP13CG: 80.47, BioNLP13GE: 82.81, BioNLP13PC: 82.68, CRAFT: 81.21,
Ex-PTM: 82.37, JNLPBA: 77.06, NCBI-Disease: 83.63*
NCBI-Disease AnatEM: 79.76, BC2GM: 78.40, BC4CHEMD: 75.16, BC5CDR: 79.98,
BioNLP09: 78.97, BioNLP11EPI: 79.75, BioNLP11ID: 79.24,
BioNLP13CG: 79.85, BioNLP13GE: 80.06, BioNLP13PC: 79.41, CRAFT: 76.96,
Ex-PTM: 80.74*, JNLPBA: 74.84, Linnaeus: 79.21
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